logo
Breaking News
  

Addex Therapeutics To Sell Up To $2.1 Mln Of ADSs

By RTTNews Staff Writer   ✉   | Published: | Follow Us On Google News

Addex Therapeutics Ltd (ADXN), a company pioneering allosteric modulation-based drug discovery and development, said on Wednesday that it signed an agreement with H.C. Wainwright & Co., LLC, to sell up to $2.1 million of its American Depository Shares or ADSs.

The company noted that it may offer or sell its ADSs from time to time at its sole discretion through H.C. Wainwright as its sales agent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
EU Designates Apple's IPadOS As Gatekeeper
The European Commission announced that it has designated Apple Inc.'s operating system for iPads, iPadOS, as a gatekeeper under the Digital Markets Act or DMA as it constitutes an important gateway for business users to reach end users. Apple now has six months to ensure that its iPadOS fully complies with EU's DMA obligations. In pre-market activity on the Nasdaq, Apple shares were gaining...
Philips Q1 Loss Widens, Backs FY24 View, Settles Respironics Litigation; Stock Surges
Shares of Philips Electronics NV surged around 47 percent in the morning trading in Amsterdam as well as around 44 percent in the pre-market activity on the NYSE after the Dutch consumer electronics giant announced Monday that Philips Respironics will pay a total of $1.1 billion to settle personal injury and medical monitoring litigation in the US. The company also announced a wider loss in its...
802 VT Frozen Recalls Frozen Meat Pizza Products
Newport, Vermont-based 802 VT Frozen is recalling around 8,221 pounds of frozen meat pizza citing misbranding and undeclared soy, a known allergen, according to the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS.
Global Economics Weekly Update - April 22 - 26, 2024

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2024 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap